Clinical Trials Directory

Trials / Completed

CompletedNCT03413371

Different Peribulbar Blocks With SPI-guided Anaesthesia for VRS (P&MSPIVRS)

Influence of SPI-guided Analgesia With Preventive Different Peribulbar Blocks (PBB) on the Presence of OCR, Postoperative Pain, PONV in Patients Undergoing VRS Under General Anaesthesia: a Randomised, Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
184 (actual)
Sponsor
Medical University of Silesia · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The aim of this randomized trial is to assess the efficacy of preventive analgesia using different peribulbar blocks (PBB) under SPI-guided anaesthesia for vitreoretinal surgery (VRS), presence of PONV (postoperative nausea and vomiting) and oculocardiac reflex (OCR) and compare Numerical Rating Scale (NRS) with Surgical Pleth Index (SPI) for monitoring pain perception postoperatively. Patients will receive general anaesthesia combined with either preventive PBB using either lidocaine with bupivacaine or bupivacaine or ropivacaine

Detailed description

Monitoring depth of anaesthesia using spectral entropy (SE) and quality of neuromuscular block are routine in modern anaesthesia, whereas monitoring of analgesia still requires further studies. Recently, the Surgical Pleth Index (SPI) was added as a surrogate variable showing the nociception-antinociception balance into abovementioned parameters constituting a novel approach in monitoring patients intraoperatively, known as adequacy of anaesthesia (AoA) or tailor-made anaesthesia. Different options of local anesthetic mixtures used for peribulbar block result in different analgetic potency. PBB is supposed to reduce requirement for intraoperative narcotic analgesics when used together with general anaesthesia and therefore may reduce the rate of PONV, OCR and perception of postoperative pain. The aim of the study is to investigate the influence of different PBBs on abovementioned outcomes.

Conditions

Interventions

TypeNameDescription
DRUGparacetamolin group P patients will receive pre-emptive analgesia using intravenous infusion of acetaminophen in a single dose of 10-15 mg per kg of body weight
DRUG0,5 % bupivacaine with of 2% lidocainein group BL patients will receive regional peribulbar block using a solution of 0,5% bupivacaine (2,5 ml) with 2% lidocaine (2,5 ml)
DRUG1 % Ropivacainein group R patients will receive regional peribulbar block using a solution of 0,75 % ropivacaine (5 ml)
DRUG0,5 % bupivacainein group B patients will receive regional peribulbar block using a solution of 0,5% bupivacaine (5 ml)

Timeline

Start date
2018-04-26
Primary completion
2022-12-20
Completion
2022-12-20
First posted
2018-01-29
Last updated
2025-09-23

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT03413371. Inclusion in this directory is not an endorsement.